Cell Banking Outsourcing Market Size, Strategic Analysis, Growth Drivers, Industry Trends, Demand and Future Opportunities and Forecast 2030
The cell banking outsourcing market was
estimated to be worth USD 10.7 billion globally in 2022, and over the course of
the forecast period, a CAGR of 18.1% is anticipated. The market is expanding
dramatically due to the rising use of stem cell treatment and the rising need
for monoclonal antibodies. Growing consumer demand for gene and cell therapies
is driving market expansion. This area of biotechnology and pharmaceuticals is
expanding quickly due to the demand for cost-effective solutions and specialist
knowledge in managing precious cell lines utilized for medicinal development
and research.
Through this outsourcing, businesses can leverage outside
knowledge for cell line management while concentrating on their core
competencies. The globalization of research and development along with
technical improvements are propelling the expansion of the outsourcing market
for cell banking.
Request
For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/cell-banking-outsourcing-market
Impact of Covid-19
COVID-19 has a major effect on the market for outsourcing
cell banking. Operations were initially impacted by personnel constraints,
restricted lab access, and supply chain problems. But the epidemic also boosted
the need for vaccinations and cell-based treatments, which led to a rise in the
outsourcing of cell banking services. Robust and adaptable outsourcing
techniques are in greater demand in order to maintain research, development,
and manufacturing processes in the face of global challenges.
Growth Drivers
Increasing demand for biopharmaceuticals: The
need for effective cell banking services to support the development and
manufacture of biopharmaceuticals and cell-based treatments is growing.
Technological advancements in cryopreservation, cell line authentication, and
cell culture procedures are driving demand for cutting-edge outsourcing
partners and technologies.
Cost-effectiveness and efficiency: Compared to setting up
and maintaining internal infrastructure, outsourcing cell banking services
should be more affordable, enabling businesses to use resources more wisely.
Pandemic Induced Demand: The covid-19 epidemic
made it even more important to have trustworthy outsourcing partners in order
to maintain production, research, and development despite setbacks.
Segmentation
Bank Types
· Master
Cell Banks
· Working
Cell Banks
· Viral
Cell Banks
By Phase
· Bank
Storage
· Cell
Storage Stability Testing
· Bank
Preparation
· Bank
Characterization and Testing
· Others
By Cell-Type
Stem Cell
· Cord
Blood Stem Cell Testing
· Embryonic
Stem Cell Banking
· Adult
Stem Cell Banking
· Dental
Stem Cell Banking
· Induced
Pluripotent Stem Cell Banking
Non-Stem Cell
Regional Outlook
· Asia
Pacific
· North
America
· Latin
America
· Europe
· Middle
East and Africa
Key Players
· Covance
· Goodwin
Biotechnology
· BSL
Bio service
· SGS
· Lonza
· Life
cell International
· Reliance
Life Science
· Cord
Life Group Limited
· Charles
River Laboratories
· Labcorp
Drug Development
· Perfectus
Biomed Limited
· Other
Players
For
More Information about this Report @ https://www.xresearch.biz/shop/cell-banking-outsourcing-market
About
Us: -
xResearch is a
market research and consulting organization that uses unique data, expert
analysis, and new technologies to create trusted intelligence on industries.
Our research is focused on delivering an informed and impartial view on
essential market data of industry, and it is primarily driven by an in-depth
study covering the following parameters: Market Sizing and Forecasting, Market
Segmentation, Competitive Analysis, Strategic Assessment and Business Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-618-4545
Comments
Post a Comment